CancerDrs

Brain Cancer clinical trials in Nevada

4 actively recruiting brain cancer trials at 3 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Academic/Other

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

This phase III trial compares temporally-modulated pulsed radiation therapy versus standard radiation therapy in treating patients with newly diagnosed, IDH wildtype, MGMT-unmethylated glioblastoma. After completion of surgery, the standar…

Sponsor: NRG Oncology
NCT ID: NCT07452458
Sites in Nevada:
  • Renown Regional Medical Center — Reno, Nevada
View on ClinicalTrials.gov →
Phase 2 Recruiting Network

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to …

Sponsor: Children's Oncology Group
NCT ID: NCT04684368
Sites in Nevada:
  • Oncology Las Vegas - Henderson — Henderson, Nevada
  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada
  • Renown Regional Medical Center — Reno, Nevada
  • Cancer Care Specialists - Reno — Reno, Nevada
View on ClinicalTrials.gov →
Phase 2 Recruiting Industry

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

This study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receiv…

Sponsor: Biostar Pharma, Inc.
NCT ID: NCT06764940
Sites in Nevada:
  • Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01